Inter- and intra-assay reproducibility of microplate alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis

Brian Leonard, Jorge Coronel, Mark Siedner, Louis Grandjean, Luz Caviedes, Pilar Navarro, Robert H. Gilman, David A.J. Moore

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

The intersample and intrasample variability of the results obtained with the microplate Alamar blue assay for the indirect drug susceptibility testing of Mycobacterium tuberculosis was investigated. Between 1.2 and 8.5% of paired MICs differed by more than one twofold dilution, resulting in discordant susceptible-resistant designations at frequencies between 0.6% (rifampin) and 18.9% (ethambutol).

Original languageEnglish (US)
Pages (from-to)3526-3529
Number of pages4
JournalJournal of clinical microbiology
Volume46
Issue number10
DOIs
StatePublished - Oct 2008

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Inter- and intra-assay reproducibility of microplate alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this